LIFE SCIENCES (UK) HOLDINGS II LIMITED
Get an alert when LIFE SCIENCES (UK) HOLDINGS II LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-12-19 (in 7mo)
Last made up 2025-12-05
Watchouts
None on the register
Cash
£391K
+36.1% vs 2023
Net assets
£121M
-7.9% vs 2023
Employees
0
Average over period
Profit before tax
-£111M
-282.6% vs 2023
Net assets
2-year trend · vs Real Estate median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£28,519,593 | -£110,148,263 | |
| Profit before tax | -£28,912,426 | -£110,606,796 | |
| Net profit | -£28,916,606 | -£110,607,116 | |
| Cash | £287,309 | £391,016 | |
| Total assets less current liabilities | £138,812,261 | £128,564,191 | |
| Net assets | £131,421,370 | £121,055,444 | |
| Equity | £131,421,370 | £121,055,444 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -20.5% | -85.7% | |
| Gearing (liabilities / total assets) | 18.8% | 6.3% | |
| Current ratio | 0.81x | 1.67x | |
| Interest cover | -72.60x | -240.22x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- PricewaterhouseCoopers CI LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In assessing whether the going concern basis of preparation is appropriate to adopt, the Directors have not identified events or conditions that may cast significant doubt on the Group's ability to be a going concern. The Directors recognise the Group's current assets exceed its current liabilities for a net current asset position of £443,616 as at 31 December 2024.”
Group structure
- LIFE SCIENCES (UK) HOLDINGS II LIMITED · parent
- Snowsfields Holdings Limited 100%
- Victoria House Holdings Limited 100%
- Oxford Biocitech Holdings Limited 100%
- Pills TopCo SCI 0.01%
Significant events
- “Subsequent to year end, the facility agreement with Crédit Agricole Corporate and Investment Bank in relation to Pills AcquisitionCo SCI, a subsidiary of Pills TopCo SCI was amended. As a result, the Group is no longer required to provide a performance guarantee as described in note 13. The release of guarantee is effective 4 February 2025 onwards.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GEN II CORPORATE SERVICES (JERSEY) LIMITED | Corporate Secretary | 2022-10-27 | — | — |
| DREXLER, Jay | Director | 2024-12-20 | Aug 1984 | Canadian |
| EVERALL, Robin James Ele William | Director | 2022-10-07 | Dec 1980 | English |
| WOODRING, Antara | Director | 2025-07-22 | Apr 1986 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CRESTBRIDGE UK LIMITED | Corporate Secretary | 2021-12-06 | 2022-10-27 |
| HODGETTS, Ann Mary | Director | 2021-12-06 | 2023-05-22 |
| LAMBERT, Alison Jane, Ms. | Director | 2021-12-06 | 2022-10-01 |
| RAWLINSON, Rebecca Mary | Director | 2024-02-01 | 2025-04-24 |
| SHAPIRO, Abigail Jane | Director | 2023-05-19 | 2024-12-20 |
| SHEARER, Henry Charles | Director | 2022-02-24 | 2022-07-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Re International Corporation | Corporate entity | voting-rights-75-to-100-percent-as-firm, right-to-appoint-and-remove-directors-as-firm | 2021-12-06 | Active |
| Life Sciences Holdings Uk Scsp | Corporate entity | ownership-of-shares-75-to-100-percent-as-firm | 2021-12-06 | Active |
Filing timeline
Last 20 of 80 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-19 | SH01 | capital | Capital allotment shares | |
| 2026-03-19 | SH01 | capital | Capital allotment shares | |
| 2026-02-06 | SH01 | capital | Capital allotment shares | |
| 2026-01-22 | SH01 | capital | Capital allotment shares | |
| 2026-01-22 | SH01 | capital | Capital allotment shares | |
| 2026-01-22 | SH01 | capital | Capital allotment shares | |
| 2025-12-08 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-12-03 | SH01 | capital | Capital allotment shares | |
| 2025-11-07 | AAMD | accounts | Accounts amended with accounts type group | |
| 2025-11-03 | SH01 | capital | Capital allotment shares | |
| 2025-08-26 | SH01 | capital | Capital allotment shares | |
| 2025-08-06 | AA | accounts | Accounts with accounts type group | |
| 2025-08-01 | SH01 | capital | Capital allotment shares | |
| 2025-07-22 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-21 | SH01 | capital | Capital allotment shares | |
| 2025-07-10 | SH01 | capital | Capital allotment shares | |
| 2025-05-22 | SH01 | capital | Capital allotment shares | |
| 2025-05-12 | SH01 | capital | Capital allotment shares | |
| 2025-04-24 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-02 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 18
- Capital events
- 15
- Officers appointed
- 1
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+36.1%
£287,309 £391,016
-
Net assets
-7.9%
£131,421,370 £121,055,444
-
Employees
—
Not reported
-
Operating profit
-286.2%
-£28,519,593 -£110,148,263
-
Profit before tax
-282.6%
-£28,912,426 -£110,606,796
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers